Related Experiment Video

Updated: May 27, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Cardiomyopathies: classification, diagnosis, and treatment

Bernhard Maisch1, Michel Noutsias, Volker Ruppert

  • 1Division of Cardiology, Department of Internal Medicine, Faculty of Medicine, Philipps University, UKGM GmbH, Baldinger Street, 35043 Marburg, Germany. maisch@staff.uni-marburg.de

Heart Failure Clinics
|November 24, 2011
PubMed

Insights

Recent cardiomyopathy classifications aid clinicians in diagnosing structural heart muscle diseases. A logical approach, including endomyocardial biopsies, helps identify genetic, autoimmune, and viral causes.

Area of Science:

  • Cardiology
  • Pathology

Background:

  • Recent classifications of cardiomyopathies by the American Heart Association and European Society of Cardiology offer new clinical applicability.
  • Understanding causative factors is crucial for diagnosing familial and nonfamilial structural heart muscle diseases.

Purpose of the Study:

  • To comment on the clinical applicability of recent cardiomyopathy classifications.
  • To emphasize a diagnostic approach for identifying causative factors in cardiomyopathies.
  • To highlight the management of inflammatory and viral cardiomyopathies.

Main Methods:

  • Review of recent American Heart Association and European Society of Cardiology classifications.
  • Discussion on the role of endomyocardial biopsies in clinical scenarios.
  • Emphasis on a logical diagnostic approach for cardiomyopathies.

Main Results:

  • Clinicians can now identify genetic, autoimmune, and viral causative factors.
  • A thorough and logical approach facilitates diagnosis in patients with structural heart muscle diseases.
  • Management strategies for inflammatory and viral cardiomyopathies are discussed.

Conclusions:

  • Recent classifications enhance clinical applicability in diagnosing cardiomyopathies.
  • A systematic approach integrating biopsy findings aids in etiological diagnosis.
  • Effective management of inflammatory and viral cardiomyopathies is achievable.

More Related Videos

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice04:45

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice

Published on: May 5, 2022

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...